Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00125606
Status:
TERMINATED
Last Update Posted:
2012-12-18
First Post:
2005-07-26
Brief Title:
Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI Fludarabine to Conditioning With TBI 12GyCyclophosphamide
Sponsor:
University Hospital Muenster
Organization:
University Hospital Muenster
Organization Data
Organization:
University Hospital Muenster
Class:
OTHER
Study ID:
AML_CR2_allo_HSCT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Muenster
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Technische Universität Dresden | OTHER |
| Philipps University Marburg Medical Center | OTHER |
| Universitätsklinikum Hamburg-Eppendorf | OTHER |
| Hannover Medical School | OTHER |
| Ludwig-Maximilians - University of Munich | OTHER |
| University Hospital Essen | OTHER |
| Johann Wolfgang Goethe University Hospital | OTHER |
| Deutsche Klinik fuer Diagnostik | OTHER |
| Charite University Berlin Germany | OTHER |